EWP
BSX icon

Engrave Wealth Partners’s Boston Scientific BSX Stock Holding History

Engrave Wealth Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-63
Closed -$2K – 102
2020
Q2 		$2K Buy
+63
New +$2.27K ﹤0.01% 386

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Engrave Wealth Partners's BSX Position: Q3 2020 in Review

Engrave Wealth Partners sold out of Boston Scientific (BSX) in Q3 2020, closing a stake of 63 shares — an estimated $2K sold.

Engrave Wealth Partners first reported a position in BSX in Q2 2020 and held it in 1 quarter. The position peaked at $2K in Q2 2020. 843 funds tracked by Wall St. Rank hold BSX as of Q3 2020.

  • Engrave Wealth Partners reported no remaining Boston Scientific position as of Q3 2020 after selling out during the quarter.
  • Engrave Wealth Partners sold 63 Boston Scientific shares in Q3 2020, an estimated $2K.
  • Engrave Wealth Partners first reported a position in Boston Scientific in Q2 2020 and held it in 1 quarter.
  • Engrave Wealth Partners's Boston Scientific position peaked at $2K in Q2 2020.
  • 843 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2020.

Based on Engrave Wealth Partners's 13F filing for Q3 2020, filed 8 Oct 2020.